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Abstract 
Although mitochondrial oxidative catabolism of fatty acid (FA) is a major 
energy source for the adult mammalian heart, cardiac lipotoxity resulting from elevated 
serum FA and enhanced FA use has been implicated in the pathogenesis of heart failure. 
To investigate the effects of the intermediates of FA metabolism, palmitoyl-L-carnitine 
(Pal-car) and palmitoyl-CoA (Pal-CoA), on mitochondrial function, we measured 
membrane potential (Δψm), opening of the mitochondrial permeability transition pore 
(mPTP) and the production of reactive oxygen species (ROS) in saponin-treated rat 
ventricular myocytes with a laser scanning confocal microscope. Our results revealed 
that: 1) lower concentrations of Pal-car (1 and 5 μM) caused a slight hyperpolarization 
of Δψm (TMRE intensity increased to 115.5 ± 5.4 % and 110.7±1.6 % of the baseline, 
respectively. p<0.05) but did not open mPTP, 2) a higher concentration of Pal-car (10 
μM) depolarized Δψm (TMRE intensity decreased to 61.9 ± 12.2 % of the baseline, 
p<0.01) and opened mPTP (calcein intensity decreased to 70.7 ± 2.8% of the baseline, 
p<0.01), 3) Pal-CoA depolarized Δψm without opening mPTP, and 4) only the higher 
concentration of Pal-car (10 μM) increased ROS generation (DCF intensity increased to 
3.4 ± 0.3 fold of the baseline). We concluded that excessive exogenous intermediates of 
long chain saturated FA may disturb mitochondrial function in different ways between 
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Pal-car and Pal-CoA. The distinct mechanisms of the deteriorating effects of long chain 
FA on mitochondrial function are important for our understanding of the development 
of cardiac diseases in systemic metabolic disorders. 
 
 
Keywords: Palmitoyl-L-carnitine and Palmitoyl CoA; mitochondrial membrane 
potential; mitochondrial permeability transition pore; ROS production  
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Introduction 
Metabolic syndrome and insulin resistance are risk factors for cardiovascular 
diseases and are frequently accompanied by high serum fatty acid (FA) levels. Recent 
studies (10, 35) have suggested that these metabolic disorders are also related to the 
development of clinical heart failure without any coronary heart disease (1). High serum 
FA levels are accompanied by an increased prevalence of serious arrhythmia and could 
be linked to a higher mortality in patients with heart failure (22, 35). Opie proposed the 
concept of ‘metabolic vicious cycle’ (24) where increasing insulin resistance and serum 
FA levels, as a consequence of the hyper-adrenergic state, could reduce myocardial 
energy efficiency in a failing heart (1). 
In studies using transgenic mice or rat models of obesity and diabetes (5, 38), it 
has been shown that the accumulation of lipids and related intermediates in 
cardiomyocytes can be a cause of cardiac lipotoxicity or cardiac cell death resulting in 
an impaired contractile function and cardiac hypertrophy. Although the role of 
metabolic alteration in the development of heart failure is not yet fully understood, it is 
suggested that cardiac lipotoxity as a result of enhanced FA metabolism plays an 
important role in the onset and development of clinical heart failure (15). 
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An overload of FA, specifically saturated long chain FA such as palmitic acid 
(PA), affects mitochondrial function and induces cardiomyocytes apoptosis (32). PA is 
converted to its coenzyme A ester form (palmitoyl-CoA; Pal-CoA) in the cytosol (12) 
and this Pal-CoA would be taken up by mitochondria as a carnitine ester form 
(palmitoyl-L-carnitine; Pal-car) immediately (33) and reconverted to Pal-CoA by 
carnitine palmitoyl-transferase II (CPT-II) in the mitochondrial matrix (12). In previous 
studies using isolated mitochondria (13, 25) or cultured cells (32, 37), PA and its 
intermediates (Pal-car and Pal-CoA) have been shown to affect mitochondrial 
membrane potential (Δψm), mitochondrial permeability transition pore (mPTP), activity 
of the respiratory chain, and generation of reactive oxygen species (ROS). Among these, 
accumulation of Pal-car and Pal-CoA in the myocytes may have an impact on 
mitochondrial function in physiological conditions. However, little is known whether 
Pal-car and Pal-CoA cause distinct responses in Δψm, mPTP, and ROS generation in 
vivo. Here, the aim of this study was to investigate the differences in effects of FA 
intermediates on mitochondrial function at the myocyte level. For this purpose, we 
perfused permeabilized ventricular myocytes with Pal-car or Pal-CoA and monitored 
Δψm, opening of mPTP, and generation of ROS.  
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Materials and Methods 
Cell isolation and permeabilization 
This investigation conforms to the Guide for the Care and Use of Laboratory 
Animals Published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996). Isolated myocytes were obtained by enzymatic dissociation from male 
Sprague-Dawley rats (250-350 g) and cells were kept in modified Kraft-Brühe (KB) 
solution (9), which contained (mM) 40 KCl, 20 KH2PO4, 3 MgCl2, 50 glutamic acid, 10 
glucose, 10 HEPES, and 0.5 EGTA (pH was adjusted to 7.4 with KOH). Just before the 
experiments, cells were placed in a chamber and incubated with normal Tyrode solution, 
composed of (mM) 143 NaCl, 5.4 KCl, 0.5 MgCl2, 0.25 NaH2PO4, 1 CaCl2, 5.6 glucose 
and 5 HEPES (pH 7.4 with NaOH). All experiments were conducted at room 
temperature (25 °C) within 6 hours of cell isolation, and all samples were perfused with 
the solutions (approximately 3.0 ml/min) according to the protocol. The sarcolemmal 
membrane of cardiac myocytes were permeabilized by saponin (0.05 mg/ml) for 30 sec 
in a Ca2+-free internal solution, which contained (mM) 50 KCl, 80 K-asparate, 2 
Na-pyruvate, 20 HEPES, 3 MgCl2-6H2O, 2 Na2ATP, 3 EGTA (pH 7.3 with KOH), and 
then saponin was removed by the continuous perfusion of a Ca2+-free internal solution 
for 2 min. Experiments were performed with a laser scanning confocal microscope 
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(LSM 510, Karl-Zeiss) coupled to an inverted microscope (Axiovert S100, Karl-Zeiss) 
with a 63 × water-immersion objective lens ([NA] =1.3: Karl-Zeiss). 
Measurement of membrane potential 
For the measurement of Δψm, permeabilized myocytes were loaded with a 
continuous perfusion of fluorescent indicator tetramethylrhodamine ethyl ester (TMRE: 
10 nM). TMRE was excited at 543 nm with a helium-neon laser, and the emission 
signals were collected through a 560 nm long-pass filter. Data is presented as the % of 
TMRE signal before the application of drugs. Fluorescence intensity was integrated 
over regions of interest (25 × 25 pixels) excluding the nuclei and the edge of the cell. 
Imaging of mPTP opening 
To evaluate mPTP opening, myocytes were loaded with calcein/AM (1 µM) for 
25 min, and then sarcolemmal membrane was permeabilized to remove cytoplasmic 
dyes. This method allows a selective loading of calcein in mitochondria. On the opening 
of mPTP, entrapped calcein is released from the mitochondrial matrix. Calcein was 
excited at 488 nm and emission was collected through a 505-550 nm band pass filter. 
After concluding the experiments with Pal-car and Pal-CoA, pore-forming antibiotic 
alamethicin (10 µg/ml) was applied to induce maximal calcein release from the 
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mitochondrial matrix and the minimum calcein fluorescence after alamethicin is 
regarded as 0 % for the normalization of calcein fluorescence. 
Measurement of ROS in skinned myocytes  
For the measurement of ROS generation, permeabilized myocytes were loaded 
with a continuous perfusion of fluorescent indicator 2’7’-dichlorofluorescin diacetate 
(DCF: 10 μM). Cells were excited at 514 nm with an argon laser, and the emission 
signals were collected through a 530 nm long-pass filter. The fluorescent intensity at 
identical regions of interest (25 × 25 pixels) were monitored every 1 min to analyze 
changes in DCF signals. 
Measurement of FAD oxidation 
The mitochondrial redox state of single myocytes was assessed by measuring 
their FAD-linked protein fluorescence. Endogenous FAD auto-fluorescence was excited 
at 488 nm with an argon laser and fluorescence was collected through a 505 nm long- 
pass filter. Two-dimensional images were acquired at 1 min intervals. The FAD signal 
decreased to a minimum in the presence of cyanide (CN-, 4 mM), an inhibitor of 
cytochrome oxidase, and increased upon exposure to the uncoupler of mitochondria,   
2, 4-dinitrophenol (DNP, 100 μM). CN- and DNP were expected to cause maximum 
reduction and oxidation (9), respectively. Each signal was calibrated as 0 % for 
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CN--induced complete reduction and as 100 % for DNP. Fluorescence intensity was 
integrated over regions of interest (25 × 25 pixels) excluding the nuclei and the edge of 
the cell. 
Chemicals and data analyses 
All chemicals were obtained from Sigma (St Louis, MO, USA) and fluorescent 
dyes were purchased from Molecular Probes (Eugene, OR, USA). Data is presented as 
means ± SE, and the number of cells or experiments is shown as n. Statistical analyses 
were performed using two-way ANOVA of repeated measurements, followed by 
Bonferroni test. A level of p<0.05 was accepted as statistically significant. 
Fatty acyl-carnitine and fatty acyl-CoA and inhibitors of CPT  
     Palmitoyl-L-carnitine (Pal-car) was dissolved in the internal solution and 
palmitoyl-CoA (Pal-CoA) was dissolved in ethanol. Ethanol was present in the perfused 
solution at a final concentration of 0.2 % and had no individual effect on TMRE, calcein, 
DCF or FAD intensity. In this study, we did not apply BSA to the solution, in order to 
avoid attenuating the activities of these fatty acyl intermediates in the solution (13). 
Perhexiline, a CPT-I and CPT-II inhibitor, and oxfenicine, a CPT-I inhibitor (11) were 
dissolved in the internal solution. 
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Results 
 Effects of Pal-car on Δψm and mPTP 
We investigated the effects of Pal-car on Δψm and mPTP. Figure 1A 
demonstrates the time course of the changes in TMRE intensity, which represent the 
changes in mitochondrial Δψm, during and after the application of Pal-car (1 to 10 μM) 
for 10 min. Pal-car (1 and 5 μM) slightly increased TMRE intensity (115.5 ± 5.4 % of 
the baseline, and 110.7±1.6 % of the baseline, respectively. p<0.05). However, higher 
concentration of Pal-car (10 μM) depolarized Δψm significantly (61.9 ± 12.2 % of the 
baseline, p<0.01). These results indicated that when appropriate concentrations of 
Pal-car were added in the internal solution and taken up by mitochondria, mitochondrial 
basal metabolism would be accelerated and Δψm was hyperpolarized slightly. On the 
other hand, the application of higher concentrations of Pal-car (and possibly higher 
concentrations of Pal-CoA inside the mitochondrial matrix and/or excessive Pal-car in 
the cytosol) results in Δψm depolarization. To differentiate this effect, the same 
experiments were conducted with perhexiline, a CPT-I and CPT-II inhibitor. When cells 
were pretreated with perhexiline (0.1 μM), subsequent application of Pal-car (1 μM in 
Figure 2A and 10 μM in Figure 2B) did not alter Δψm, indicating that the observed 
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changes in Δψm were related to the uptake of Pal-car into the mitochondrial matrix and 
to its metabolism. 
The opening of mPTP has been suggested to be a mechanism of FA-induced 
mitochondrial damage (2, 13). We hypothesized that the opening of mPTP could be 
involved in Pal-car-induced Δψm depolarization. We have previously reported that the 
reduction of mitochondrial trapped calcein intensity indicates the opening of mPTP in 
permeabilized myocytes (9). Figure 1B demonstrates the changes in calcein intensity 
during and after 10 min perfusion of Pal-car. The pore-forming antibiotic alamethicin 
was applied after the perfusion of Pal-car to complete maximal release of calcein from 
the mitochondrial matrix, providing positive control. Application of 1 μM Pal-car did 
not cause any changes in calcein intensity (95.4 ± 2.9 % of the baseline) compared to 
the control. However, 10 μM Pal-car decreased calcein intensity significantly     
(70.7 ± 2.8 % of the baseline, p<0.01 vs. control). An mPTP inhibitor, cyclosporine A 
(CsA; 0.1 μM) attenuated Pal-car-induced reduction of calcein signal (84.5 ± 0.2 % of 
the baseline). From these results, it was shown that there were biphasic effects of 
Pal-car on Δψm and mPTP, that is, only higher concentrations of Pal-car depolarized 
Δψm and opened mPTP.  
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Effects of Pal-CoA on Δψm and mPTP  
Under conditions of increased plasma free FA levels, the concentration of 
Pal-CoA in cytosolic space would also be increased (30). We next investigated the 
effects of Pal-CoA on Δψm and mPTP. In this series of experiments, cells were 
permeabilized and L-carnitine did not exist in the internal solution. Therefore, this 
suggested that Pal-CoA applied to the internal solution could not enter into the 
mitochondrial matrix since the conversion of Pal-CoA to Pal-car might not occur. 
Figure 3A shows the time course of the changes in TMRE intensity during 10 min 
perfusion of Pal-CoA (0.1 to 10 μM) and after the wash out. In contrast to Pal-car, 
Pal-CoA (0.1 to 5 μM) decreased TMRE signal at 10 min (90.8 ± 3.8 % with 0.1 μM, 
84.7 ± 2.8 % with 0.5 μM, 65.8 ± 4.2 % with 1 μM, and 56.9 % ± 13.0 % with 5 μM, 
p<0.05 and p<0.01 vs. baseline) dose-dependently. However, when cells were exposed 
to a higher concentration of Pal-CoA (10 μM), Δψm dissipated rapidly and completely 
within a few minutes. These results suggest that the accumulation of Pal-CoA in the 
cytosolic space altered Δψm, and the higher concentration of Pal-CoA might be harmful 
to the maintenance of mitochondrial function.  
We next examined whether Pal-CoA could open mPTP by measuring the 
reduction of calcein intensity. The time course of the changes in calcein intensity in the 
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presence of Pal-CoA is shown in Figure 3B. In contrast to the effects of Pal-car on 
mPTP (Figure 1B), the reduction of calcein intensity by Pal-CoA (1 to 10 μM), which 
were the concentrations to depolarize Δψm, was the same as that of the control perfusion. 
These results suggest that the depolarization or dissipation of Δψm by Pal-CoA is not 
related to the opening of mPTP. 
Effects of Pal-car and Pal-CoA on the generation of ROS 
It has been suggested that ROS generation is related to FA-induced mitochondrial 
damage and apoptosis (29) and that ROS was a potent inducer of mPTP opening (7). 
Figure 4 shows the time course of the changes in DCF intensity during and after the 10 
min perfusion of Pal-car (1 and 10 μM) and Pal-CoA (10 μM). The data shows that    
1 μM Pal-car promoted a gradual and modest increase (1.6 ± 0.2 fold of the baseline, 
p<0.05 vs. the baseline) in DCF fluorescence, and that the application of 10 μM Pal-car 
caused a rapid and larger increase (3.4 ± 0.3 fold of the baseline, p<0.01 vs. the 
baseline) in DCF intensity and DCF fluorescence decreased rapidly after the withdrawal 
of Pal-car. Since the decrease in DCF signal can not be due to the reduction of DCF by 
intracellular reductases and the efflux of oxidized DCF from mitochondria is dependent 
on ΔpH (membrane potential and proton gradient), a modest recovery of Δψm after 
Pal-car washout may have affected the efflux of this dye. In addition, a constant 
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perfusion of internal solution during protocols could wash out the leaked DCF 
immediately. 
When cells were exposed to 10 μM Pal-car for 5 min, and then a ROS scavenger, 
N-acetylcysteine (NAC; 400 μM) (21), added to the internal solution in the continuous 
presence of 10 μM Pal-car, the increase in DCF intensity was completely eliminated, 
confirming that these changes in DCF fluorescence were attributed to the generation of 
ROS. In contrast to Pal-car, when cells were exposed to 10 μM Pal-CoA for 10 min, 
there was only a transient and slight increase in DCF signal (1.8 ± 0.2 fold of baseline, 
p<0.05 vs. the baseline) followed by the reduction of the signal. Thus, the mechanisms 
of ROS generation by Pal-car and Pal-CoA were shown to be different and that only the 
perfusion of Pal-car generated ROS significantly in the mitochondrial matrix. 
MPTP inhibitor and ROS scavenger prevented Pal-car-induced Δψm depolarization 
The changes in TMRE intensity with Pal-car (10 μM) in the presence of 
cyclosporine A (CsA), an mPTP inhibitor, are shown in Figure 5A. When cells were 
pretreated with CsA (0.1 μM), the reduction of TMRE intensity by Pal-car (10 μM) was 
notably inhibited (87.7 ± 6.2 % of baseline, p<0.01 vs. Pal-car alone). To further 
confirm that the mPTP-mediated depolarization of Δψm can be related to the generation 
of ROS, the effects of NAC on Pal-car-induced Δψm depolarization was investigated. 
 - 15 - 
As shown in Figure 5B, pretreatment with NAC (400 μM) slightly increased       
(107 ± 3.0 % of baseline, p<0.01 vs. Pal-car alone) rather than decreased TMRE signals 
after the application of Pal-car (10 μM). These results indicate that both a CsA-sensitive 
opening of mPTP and ROS generation are related to the depolarization of Δψm induced 
by Pal-car under our experimental conditions. 
Extra-mitochondrial Pal-CoA did not alter mitochondrial redox state 
As shown in Figures 3A and 3B, Pal-CoA depolarized Δψm without opening 
mPTP. We then applied Pal-CoA and L-carnitine simultaneously to encourage the 
uptake of Pal-CoA into the mitochondrial matrix. When cells were pretreated with 
L-carnitine (2.5 mM) (6) and then exposed to 10 μM Pal-CoA simultaneously, the 
Pal-CoA-induced depolarization of Δψm was prevented significantly. In addition, this 
Δψm preventing effect of L-carnitine was inhibited by CPT-I inhibitor, oxfenicine (10 
μM) (Figure 6A). These results indicated that the stimulation of mitochondrial Pal-CoA 
uptake with L-carnitine prevented the deleterious effects of extra-mitochondrial 
Pal-CoA. 
Finally, we investigated how Pal-CoA depolarized Δψm. Previous studies 
proposed several mechanisms for the depolarization of Δψm induced by Pal-CoA (2), 
such as the direct inhibition of the respiratory chain, the generation of ROS, and 
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increased proton leak. We have already shown that the application of Pal-CoA caused 
only a small and transient ROS generation (Figure 4). In this study, we assessed the 
activity of the respiratory chain by measuring FAD auto-fluorescence. Acceleration of 
the respiratory chain increases oxidation of FADH to FAD, resulting in the elevation of 
FAD auto-fluorescence. When myocytes were perfused with 10 μM Pal-CoA for 10 min, 
there were no changes in FAD auto-fluorescence (Figure 6B). These results suggest that, 
under our experimental conditions, the direct effect of Pal-CoA on the respiratory chain 
was unlikely.  
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Discussion 
It is well established that an accumulation of excess FA in cardiac myocytes 
leads to cardiac lipotoxity, which is associated with the development of heart failure (1, 
38). Since lipotoxity from the accumulation of long chain FA is specific for saturated 
FA (15), we investigated the effects of Pal-car and Pal-CoA, the intermediates of the 
most common saturated FA, on Δψm, opening of mPTP, and the generation of ROS in 
saponin-treated permeabilized cardiac myocytes. In this study, we demonstrated that (1) 
lower concentrations of Pal-car caused a slight hyperpolarization of Δψm, but did not 
open mPTP, (2) the higher concentration of Pal-car depolarized Δψm and opened mPTP, 
(3) Pal-CoA depolarized Δψm without opening mPTP, and (4) only the higher 
concentration of Pal-car increased ROS generation. These results indicate that there are 
different actions between Pal-car and Pal-CoA on mitochondrial function. 
Previous studies examining the effects of long chain FA or their intermediates 
on mitochondrial function were conducted mainly using isolated mitochondria (13, 25) 
or cultured cells (32, 37). Compared to those experiments with isolated mitochondria, 
the use in this study of permeabilized myocytes provides an opportunity to examine 
mitochondrial function under more physiological circumstances (14), and allows the 
cytosolic concentration of Pal-car or Pal-CoA to be controlled without changing the 
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conditions of the extra-mitochondrial medium (i.e. cytosolic Ca2+, ATP or other 
substrates) and intracellular architectures (14, 27). The concentrations of Pal-car (18, 
20) or Pal-CoA (31) used in this study were within the ranges reported in previous 
studies.  
The effects of Pal-car on Δψm and mPTP 
We demonstrated the biphasic effect of Pal-car on Δψm, where only the higher 
concentration of Pal-car (10 μM) depolarized Δψm, while lower concentrations of 
Pal-car (1 and 5 μM) hyperpolarized Δψm (Figure 1A). These effects of Pal-car were 
prevented with CPT inhibitor perhexiline (Figures 2A and 2B), which has been reported 
to inhibit both CPT-I and CPT-II (11). Since the inhibition of CPT-II blocked the 
conversion of Pal-car to Pal-CoA in the inner membrane, it is suggested that the 
observed changes in Δψm were indeed related to the uptake of Pal-car into the 
mitochondrial matrix and to its metabolism. It has been reported that, in the cytosolic 
space of rat ventricular myocytes, the concentration of Pal-car was 2-2.5 μM (8). After 
Pal-car enters the mitochondrial matrix and is re-converted to Pal-CoA, it can be 
oxidized and stimulates an electron transport. The hyperpolarization of Δψm could be 
due to the acceleration of the respiratory chain achieved from the optimal supply of 
Pal-CoA as an energy substrate (17). In the experiments on isolated mitochondria,    
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10 μM Pal-car has been used as the substrate for mitochondrial respiration. Differences 
in experimental conditions may explain these discrepancies. 
We also demonstrated that 10 μM Pal-car decreased calcein intensity 
significantly, which was blocked by CsA (Figure 1B), suggesting that Pal-car (10 μM) 
opened mPTP. Since CsA also inhibited Pal-car-induced depolarization of Δψm (Figure 
5A), the opening of mPTP could explain the depolarization of Δψm by a higher 
concentration of Pal-car. The direct action of Pal-car on mPTP has not been reported, 
although a previous study reported that much higher concentrations of Pal-car (at least 
25 μM) was required to enhance its amphiphilic effect (16). However, when 10 μM 
Pal-car was introduced in the cytosolic space and the uptake of Pal-car into 
mitochondria matrix was inhibited by perhexiline, there were no changes in Δψm under 
our experimental conditions (Figure 2B). When a large amount of Pal-car enters the 
matrix, concentrated Pal-car itself could serve as an amphiphile to damage mitochondria. 
Since most Pal-car is converted rapidly to Pal-CoA, existing amounts of Pal-car are 
estimated to be less than 15 % of total carnitine in the mitochondrial matrix (8). It is, 
therefore, unlikely that excessive Pal-car, either inside or outside mitochondria, altered 
Δψm or opened mPTP directly. 
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The effects of Pal-CoA on Δψm and mPTP 
Pal-CoA plus L-carnitine was applied to the internal solution in order to 
facilitate Pal-CoA transportation across the inner mitochondrial membrane, as cytosolic 
L-carnitine may not exist by itself after permeabilization of the plasma membrane. In 
this study, we showed that Pal-CoA depolarized Δψm (Figure 3A) and that the 
application of L-carnitine (6) with Pal-CoA inhibited the Pal-CoA-induced 
depolarization (Figure 6A), indicating that an excessive amount of extra mitochondrial 
Pal-CoA impairs mitochondrial function. These results are in good agreement with a 
previous study that demonstrated that L-carnitine has protective effects against mPTP 
and ischemia/reperfusion injury (26). It has been reported that when chronic substrate 
supply exceeds the capacity of oxidation or when the oxidation process is compromised, 
intracellular lipid metabolites accumulate, which leads to arrhythmia and contractile 
dysfunction (22, 23).   
Several mechanisms could be involved in the depolarization of Δψm induced by 
fatty acyl-CoA; (1) membrane peroxidation, (2) the direct inhibition of the respiratory 
chain, (3) opening mPTP, and (4) proton leaking effects (2). Fatty acyl-CoA inserts its 
hydrophobic moiety and binds to biological membranes because of its amphiphilic 
effect (2). Pal-CoA induces a peroxidation of the membrane at concentrations as low as 
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10 μM (16) and depolarizes Δψm due to amphiphilic properties outside mitochondria (4, 
16). Pal-CoA promotes mPTP opening by either (1) its interaction on adenine 
nucleotide translocase (ANT) increasing the probability of mPTP opening (direct effect) 
(28, 36) or (2) its protonophoric effects depolarizes Δψm and it opens mPTP (indirect 
effect) (2, 13).  
In this study, Pal-CoA did not accelerate calcein leakage from mitochondria in 
spite of the complete dissipation of Δψm (Figures 3A and 3B). In addition, we did not 
observe any changes in FAD auto-fluorescence from Pal-CoA (Figure 6B), indicating 
that Pal-CoA did not alter the mitochondrial redox-state significantly, and that the 
inhibitory effect of Pal-CoA on the respiratory chain was not significant. Previous 
studies have reported on the protonophoric properties of long chain FA (13, 16, 36), and 
the strongest activity was found for C12-C16 saturated FA (2). However, fatty 
acyl-CoA does not exert protonophoric activity nor uncouple oxidative phosphorylation, 
because they are unable to cross the inner mitochondrial membrane and they do not 
flip-flop because of the large hydrophilic CoA head (2). Taken together, it is likely that 
Pal-CoA-induced depolarization or dissipation of Δψm could be due to the proton 
leaking effects of Pal-CoA acting from outside the mitochondria. 
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The effects of Pal-car and Pal-CoA on ROS generation 
In this study, we demonstrate that Pal-car increased ROS generation (Figure 4) 
and that NAC prevented the depolarization of Δψm (Figure 5B), suggesting the 
contribution of Pal-car-induced ROS generation to the opening of mPTP. On the other 
hand, Pal-CoA caused ROS generation only for a short period and total amounts of ROS 
were significantly smaller compared with those of Pal-car. The distinct responses of 
ROS generation caused by FA intermediates has not previously been reported and this is 
the first study to demonstrate that there are significant differences between Pal-car and 
Pal-CoA induced ROS generation in skinned myocytes. 
The mechanism of mitochondrial ROS generation induced by FA remains to be 
clarified. Several studies reported that direct inhibition of the respiratory chain was 
attributed to ROS generation by FA (13, 32). Schönfeld and Wojtczak (29) reported that 
FA abolishes ROS generation in rat heart mitochondria when electron transport was 
reversed. As Pal-car supplies electrons and stimulates (rather than inhibits) the 
mitochondrial respiratory chain (29), it is postulated that the acceleration of electron 
transport might contribute, at least in part, to Pal-car-induced ROS generation under our 
experimental conditions. It has been reported that a transient increase in ROS triggers a 
burst generation of ROS in neighboring mitochondria (ROS-induced ROS-release; 
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RIRR) (39). This RIRR may explain the rapid and larger increase in DCF fluorescence 
caused by Pal-car observed in this study. Pal-CoA may alter the mitochondrial 
membrane structure by its amphiphilic properties (3) and generated ROS may cause 
peroxidation of the mitochondrial membrane (16). These structural and functional 
changes could be responsible for the observed Pal-CoA-induced ROS generation. It has 
also been reported that Pal-CoA could stimulate ROS generation by inhibiting ANT 
(13). Further studies are required to identify the distinct mechanism of mitochondrial 
ROS generation between Pal-car and Pal-CoA. 
Clinical implication 
In patients with metabolic disorders, such as metabolic syndrome, obesity, and 
diabetes mellitus (19), cardiac lipotoxity has been implicated in the pathogenesis of 
clinical heart failure as a result of enhanced FA metabolism secondary to elevated 
serum FA (15). Recent clinical studies using positron emitted tomography (PET) 
techniques have provided evidence of higher myocardial FA uptake ratios in patients 
with heart failure (34) and an increased FA utilization and accumulation of FA that 
could lead to myocardial dysfunction (1, 2). Our results suggest that the excessive 
exogenous intermediates of long chain saturated FA may disturb mitochondrial function 
in different ways between Pal-car and Pal-CoA. These findings may be useful to 
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establish strategies for the treatment of heart failure caused by the impairment of FA 
metabolism. 
Conclusion 
This study demonstrates that excessive amounts of Pal-car, which could result 
in an inappropriate increase of Pal-CoA in the mitochondrial matrix, are harmful to 
mitochondrial function by accelerating ROS production and by increasing the 
probability of opening mPTP. On the other hand, an excessive cytosolic Pal-CoA itself 
may affect mitochondrial function by causing a loss of Δψm from outside the 
mitochondria. These distinct mechanisms of the deteriorating effects of long chain FAs 
on mitochondrial function are important for our understanding of the development of 
cardiac diseases in systemic metabolic disorders.  
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Figure legends 
 
Palmitoyl-L-carnitine (Pal-car) depolarized Δψm and opened mPTP  
(A) Effects of Pal-car on Δψm: The time course of the changes in TMRE intensity during and after 10 min perfusion 
of Pal-car. Sarcolemmal membrane of rat cardiac myocytes was permeabilized by 0.05 mg/ml of saponin, and then, 
as indicated by the bars at the top, permeabilized myocytes were exposed to 1-10 μM of Pal-car (1 μM; ■, n=8, 
5 μM; □, n=5, 10  μM; ●, n=9) for 10 min in a Ca2+-free internal solution. Pal-car was removed by the continuous 
perfusion of a Ca2+-free internal solution. As a reference, an uncoupler DNP (100 μM) was applied at the end of the 
experiments. Data is presented as the % of TMRE intensity before Pal-car application (* p<0.05 vs. the baseline, † p< 
0.01 vs. 1 or 5 μM Pal-car, by two-way ANOVA and Bonferroni test). 
(B) Effects of Pal-car on calcein intensity: The time course of the changes in calcein signals during and after 10 
min perfusion of Pal-car. As indicated by the bars at the top, saponin-permeabilized myocytes were exposed to 1-10 
μM of Pal-car (control; △, n=15, 1 μM; ■, n=7, 10 μM; ●, n=7) for 10 min in a Ca2+-free internal solution. In CsA 
treated cells, CsA (0.1 μM) was pretreated for 2 min to inhibit the mPTP opening, and then  
10 μM Pal-car was perfused in the presence of CsA (○; n=7). After 10 min perfusion of Pal-car or Pal-car plus CsA, 
the pore-forming antibiotic alamethicin was applied for the complete reduction of calcein intensity, providing a 
positive control of maximal calcein release from the mitochondrial matrix. Data is normalized with the baseline 
(100 %) and alamethicin-induced minimum calcein intensity (0 %). († p< 0.01 vs. control, by two-way ANOVA and 
Bonferroni test). 
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Perhexiline inhibited Pal-car-induced changes in Δψm 
(A) The time course of the changes in TMRE signals during and after 10 min perfusion of Pal-car (1 μM): 
Permeabilized myocytes were exposed to Pal-car (1 μM, ■, n=8) for 10 min in a Ca2+-free internal solution. In a 
perhexiline (PHX) treated group, after 3 min pretreatment of perhexiline (0.1 μM), cells were exposed to Pal-car (1 
μM) in the presence of perhexiline (□, n=6) for 10 min. Then, Pal-car and PHX were removed by a continuous 
perfusion of a Ca2+-free internal solution. As a reference, DNP (100 μM) was applied at the end of experiments. Data 
is presented as % the of the baseline TMRE intensity. Values are means ± SE. († p < 0.01, Pal-car vs. Pal-car + PHX, 
* p < 0.05, Pal-car vs. Pal-car + PHX, by two-way ANOVA and Bonferroni test) 
(B) The same protocol was conducted with 10 μM Pal-car: ‘■’ represents Pal-car (n=8) and ‘○’ represents Pal-car 
+ PHX (n=6). Values are means ± SE. († p < 0.01, Pal-car vs. Pal-car + PHX, * p < 0.05, Pal-car vs. Pal-car + PHX, 
by two-way ANOVA and Bonferroni test) 
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Palmitoyl-CoA (Pal-CoA) depolarized Δψm but did not open mPTP  
(A) Effects of Pal-CoA on Δψm: The time course of the changes in TMRE intensity during and after 10 min 
perfusion of Pal-CoA. The permeabilized cells were exposed to 0.1-10 μM of Pal-CoA (0.1 μM; ◆, n=8, 0.5 μM; ◇, 
n=13, 1 μM; ■, n=11, 5 μM; □, n=8, 10 μM; ●, n=4) for 10 min in a Ca2+-free internal solution as indicated by the 
bars at the top. Pal-CoA was removed by the perfusion of a Ca2+-free internal solution. As a reference, an uncoupler 
DNP (100 μM) was applied at the end of the experiments. Data is presented as the % of TMRE intensity before 
Pal-CoA application (* p<0.05 vs. the baseline, † p< 0.01 vs. the baseline by two-way ANOVA and Bonferroni test). 
(B) Effects of Pal-CoA on calcein intensity: The time courses of the changes in calcein signals during and after 10 
min perfusion of Pal-CoA. (△; control; n=15). Cells were perfused with 1 μM (■; n=4), 5 μM (□; n=12) and 10 μM 
(●; n=10) Pal-CoA. After 10 min perfusion of Pal-CoA, alamethicin was applied for a positive control of maximal 
calcein release from the mitochondrial matrix. Data is normalized with baseline (100 %) and alamethicin-induced 
minimum calcein intensity (0 %). 
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Pal-car accelerated ROS generation, but Pal-CoA did not 
The time course of the changes in DCF fluorescence during and after the application Pal-car (1 μM; ■, n=8, 10 μM; ●, 
n=11) or Pal-CoA (10 μM; ◆, n=4) for 10 min as indicated in the bar. Pal-car or Pal-CoA was removed by a 
continuous perfusion of a Ca2+-free internal solution. In N-acetylcysteine (NAC)-treated cells, NAC (400 μM) was 
added to the solution 5 min after the perfusion of Pal-car (10 μM) (Pal-car + NAC; ○, n=5) in order to scavenge ROS. 
Data is presented as multiples of the baseline before Pal-car or Pal-CoA application (* p<0.05 vs. the baseline, † p< 
0.01 vs. the baseline, by two-way ANOVA and Bonferroni test). 
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CsA and NAC inhibited Pal-car-induced Δψm depolarization  
(A) Effects of CsA on Pal-car-induced Δψm depolarization: The time course of the changes in TMRE intensity by 
Pal-car (10 μM) in the absence (●; n=9) and presence of CsA (○, n=7). Cells were pretreated with CsA (0.1 μM) for 5 
min, and then Pal-car was applied in the presence of CsA as indicated by the bars at the top. Pal-car or CsA were 
removed by the perfusion of a Ca2+-free internal solution. As a reference, DNP (100 μM) was applied at the end of 
the experiments. Data is presented as the % of TMRE intensity before Pal-car application († p< 0.01, by two-way 
ANOVA and Bonferroni test).  
(B) Effects of NAC on Pal-car-induced Δψm depolarization: The time course of the changes in TMRE intensity by 
Pal-car (10 μM) in the absence (●; n=9) and presence of NAC (○; n=12). Cells were pretreated with NAC (400 μM) 
for 5 min, and then Pal-car was added to the solution in the continuous presence of NAC for 10 min as indicated by 
the bars at the top. As a reference, DNP (100 μM) was applied at the end of the experiments. Data is presented as 
the % of TMRE intensity before Pal-car application  († p<0.01, by two-way ANOVA and Bonferroni test).  
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(A) L-carnitine prevented Pal-CoA-induced Δψm depolarization  
The time course of changes in TMRE intensity by Pal-CoA in the absence (●; n=5) and presence of L-carnitine (○; 
n=6). Cells were pretreated with L-carnitine (2.5 mM) for 5 min, and then Pal-CoA (10 μM) was applied for 10 min 
in the continuous presence of L-carnitine as indicated by the bars at the top. Pal-CoA and L-carnitine were removed 
by the perfusion of a Ca2+-free internal solution. In the oxfenicine (OXF) treated group, cells were perfused with 
OFX (10 μM) 3 min before the application of Pal-CoA (□; n=7). As a reference, DNP (100 μM) was applied at the 
end of the experiments. Data is presented as the % of TMRE intensity before Pal-CoA application († p<0.01 vs. 
Pal-CoA alone by ANOVA and Bonferroni test).  
(B) Pal-CoA did not alter FAD auto-fluorescence 
The time course of the changes in FAD signal during and after 10 min application of Pal-CoA (10 μM) in 
permeabilized myocytes (●; n=5). As indicated in the bar, at the end of the experiments, DNP (100 μM) and sodium 
cyanide (cyan: 4 mM) were applied as the references. Data are presented as the % of normalized FAD signal; i.e. 
referred to as 100 % for DNP -induced maximum oxidation and as 0 % for cyanide-induced reduction. 
